MREO

Mereo BioPharma
MREO

Overview Fund Activity

90 hedge funds and large institutions have $403M invested in Mereo BioPharma in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 7 closing their positions.

Holders
90
Holders Change
+13
Holders Change %
+16.88%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
20
Increased
20
Reduced
25
Closed
7
Calls
$3.02M
Puts
$1.84M
Net Calls
+$1.19M
Net Calls Change
+$257K

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$59.8M
2
UBS Group
2
UBS Group
Switzerland
$9.27M
3
Morgan Stanley
3
Morgan Stanley
New York
$12.4M
4
GPP
4
Great Point Partners
Connecticut
$4.03M
5
UBS AM
5
UBS AM
Illinois
$3.38M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$13.9M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$30.5M
3
TC
3
Tejara Capital
United Kingdom
$8.11M
4
ACP
4
Acuta Capital Partners
California
$2.73M
5
6CM
5
683 Capital Management
New York
$15.9M
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$59.8M 17,122,563 +4,776,697 +39%
RCMNY
2
Rubric Capital Management (New York)
New York
$53.6M 15,307,347 – –
RSCM
3
Rock Springs Capital Management
Maryland
$33.6M 9,599,170 +65,000 +0.7%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$30.5M 8,715,013 -1,000,000 -10%
MP
5
Mangrove Partners
Connecticut
$30.2M 8,636,485 -93,235 -1%
DM
6
Deerfield Management
New York
$23.5M 6,710,429 – –
FLSM
7
Frazier Life Sciences Management
California
$17.8M 5,097,779 – –
Alkeon Capital Management
8
Alkeon Capital Management
New York
$16.4M 4,698,100 – –
6CM
9
683 Capital Management
New York
$15.9M 4,550,000 -299,800 -6%
Millennium Management
10
Millennium Management
New York
$13.9M 3,965,432 -1,429,259 -26%
Morgan Stanley
11
Morgan Stanley
New York
$12.4M 3,554,234 +1,206,409 +51%
CC
12
Clearline Capital
New York
$11.3M 3,217,894 -26,440 -0.8%
UBS Group
13
UBS Group
Switzerland
$9.27M 2,648,140 +2,648,140 New
TC
14
Tejara Capital
United Kingdom
$8.11M 2,317,085 -512,905 -18%
Goldman Sachs
15
Goldman Sachs
New York
$7.42M 2,119,852 +111,471 +6%
Renaissance Technologies
16
Renaissance Technologies
New York
$4.16M 1,189,471 -115,900 -9%
GPP
17
Great Point Partners
Connecticut
$4.03M 1,150,000 +1,150,000 New
PA
18
Perceptive Advisors
New York
$3.8M 1,085,512 +269,790 +33%
IHAM
19
Integral Health Asset Management
New York
$3.5M 1,000,000 – –
UBS AM
20
UBS AM
Illinois
$3.38M 964,900 +964,900 New
TE
21
Tema ETFs
New York
$3.12M 890,548 +890,548 New
Marshall Wace
22
Marshall Wace
United Kingdom
$3.03M 866,317 -162,195 -16%
NIM
23
NEOS Investment Management
Connecticut
$2.89M 824,603 -10,591 -1%
SCM
24
Soleus Capital Management
Connecticut
$2.75M 786,953 -60,000 -7%
ACP
25
Acuta Capital Partners
California
$2.73M 779,308 -481,392 -38%
1
2 3 4